These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. Meiner Z; Ben-Hur T; River Y; Reches A J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):830-1. PubMed ID: 8380010 [No Abstract] [Full Text] [Related]
27. [Contribution of intravenous immunoglobulins to the treatment of myasthenia]. Gajdos P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986 [TBL] [Abstract][Full Text] [Related]
29. [Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis]. Puy-Nunez A; Dacosta-Balboa M; Cabo-Lopez I; Canneti B; Lopez-Ferreiro A; Rodriguez-Alvarez JR; Rodriguez-Regal A; Mourino-Sestelo MA Rev Neurol; 2016 May; 62(10):478-9. PubMed ID: 27149191 [No Abstract] [Full Text] [Related]
30. Simultaneous multiple cranial nerve neuropathies and intravenous immunoglobulin treatment in diabetes mellitus. Uluduz D; Bozluolcay M; Ince B; Kiziltan M Neurol India; 2006 Sep; 54(3):308-9. PubMed ID: 16936399 [TBL] [Abstract][Full Text] [Related]
31. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040 [TBL] [Abstract][Full Text] [Related]
32. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins. Bentes C; de Carvalho M; de Sá J; Luís ML Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759 [TBL] [Abstract][Full Text] [Related]
33. IVIG in myasthenia gravis: getting enough "bang for the buck". Meriggioli MN Neurology; 2007 Mar; 68(11):803-4. PubMed ID: 17353466 [No Abstract] [Full Text] [Related]
37. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)]. Lavrnić DB; Stojanović V; Marinković Z; Pavlović S; Vidaković A; Apostolski S Srp Arh Celok Lek; 1995; 123(5-6):146-8. PubMed ID: 17974459 [TBL] [Abstract][Full Text] [Related]
38. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C; J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469 [TBL] [Abstract][Full Text] [Related]